blog

The biotech industry appears to be sending mixed signals Across biotech, programmes are being paused, clinical trials are being terminated […]

It is possible to set targets that comply with the SMART pattern and still find that, when achieved, we are

In the early stages of development, many small biotech companies are focused on advancing their science, securing funding, and reaching

Working in GxP environments has changed my approach to project management. One of the biggest lessons was discipline. In GxP,

This statutory instrument amends the Medicines for Human Use (Clinical Trials) Regulations 2004 (2004 No.1031). The legislation aims to protect

When people think about patient safety in clinical and regulated environments, they often picture clinicians, investigators, or auditors. These roles

The medical device landscape is evolving fast driven by innovation, digital technologies, and tighter global regulations. At the center of

It’s a new year. I wish you a rewarding and joyful 2026. At this fairly arbitrary point in our journey

As we progress further into the new year, I’ve been taking time to reflect on what I want to carry forward as a Project Coordinator,

For over a century, medical devices carried a name that implied neutrality: tools, instruments, machines. Device – from Latin dispositus